XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31

EXICURE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.03−0.09 (-8.04%)

Close on Oct 19, 2026

Market cap: $6.57M
P/E (TTM): –
Dividend yield: –

EXICURE, INC. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	0	0.50	0	29	-0.48	17	1.30	0.12	9.72	1.04
Research & Development	3.29	0	1.42	20	49	32	19	14	13	14
General & Administrative	6.83	5.45	12	11	13	9.96	8.57	7.82	7.05	3.54
Operating Expenses	4.23	13	15	31	62	42	28	22	20	17
Operating Income	-4.23	-12	-15	-1.83	-63	-25	-27	-22	-10	-16
Interest Expense	0.00	0.02	0	0.60	1.69	0.57	0.79	0.67	0.80	0.72
Interest & Investment Income	0.03	0.01	0.03	0.02	0.14	0.97	0.18	–	–	–
Other Non-Operating Income	-1.35	2.54	-1.92	-0.54	-1.55	0.77	0.31	-0.59	-0.60	-0.78
Merger & Restructuring Charges	–	–	–	0.49	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.09	0	-0.92	0	–	–	–	–	–	–
Legal Settlements	0	-1.56	-0.94	–	–	–	–	–	–	–
Pretax Income	-5.58	-9.69	-17	-2.37	-64	-25	-26	–	-12	-17
Income Tax Expense	-0.63	0.01	0	0.21	0	0	0	0	0	0
Net Income	-4.95	-9.70	-17	-2.58	-64	-25	-26	-22	-11	-17
Net Income to Common	-4.95	-9.70	-17	-2.58	-64	-25	–	–	–	–
EPS (Basic)(per share)	-0.79	-4.75	-10.55	-2.80	-108.50	-42.00	-69.00	-81.00	-163.50	-22,405.50
EPS (Diluted)(per share)	-0.79	-4.75	-10.55	-2.80	-108.50	-42.00	-69.00	-81.00	-163.50	-22,405.50
Shares Outstanding (Basic, Weighted)(shares)	6.30	2.04	1.60	0.92	0.59	0.58	0.38	0.27	0.07	0.00
Shares Outstanding (Diluted, Weighted)(shares)	6.30	2.04	1.60	0.92	0.59	0.58	0.38	0.27	0.07	0.00
EBITDA	-3.99	-12	-14	-0.67	-61	-25	-26	-21	-10	-16

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -92.5%

Financial strength

Current ratio: 0.56
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 41.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 6.72
Dividend yield: –